Nomura Asset Management’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $193K | Sell |
1,275
-10
| -0.8% | -$1.52K | ﹤0.01% | 877 |
|
|
2025
Q1 | $193K | Sell |
1,285
-14,409
| -92% | -$2.17M | ﹤0.01% | 887 |
|
|
2024
Q4 | $2.9M | Buy |
15,694
+102
| +0.7% | +$18.8K | 0.01% | 681 |
|
|
2024
Q3 | $3.07M | Buy |
15,592
+1,882
| +14% | +$371K | 0.01% | 673 |
|
|
2024
Q2 | $2.83M | Buy |
13,710
+132
| +1% | +$27.3K | 0.01% | 656 |
|
|
2024
Q1 | $3.68M | Sell |
13,578
-103
| -0.8% | -$27.9K | 0.01% | 610 |
|
|
2023
Q4 | $3.23M | Buy |
13,681
+1,261
| +10% | +$298K | 0.01% | 640 |
|
|
2023
Q3 | $2.43M | Sell |
12,420
-60
| -0.5% | -$11.8K | 0.01% | 666 |
|
|
2023
Q2 | $2.62M | Sell |
12,480
-366
| -3% | -$77K | 0.01% | 667 |
|
|
2023
Q1 | $2.59M | Buy |
12,846
+895
| +7% | +$181K | 0.01% | 649 |
|
|
2022
Q4 | $2.6M | Buy |
11,951
+74
| +0.6% | +$16.1K | 0.02% | 631 |
|
|
2022
Q3 | $2.34M | Buy |
11,877
+828
| +7% | +$163K | 0.01% | 639 |
|
|
2022
Q2 | $2.36M | Buy |
11,049
+71
| +0.6% | +$15.2K | 0.01% | 663 |
|
|
2022
Q1 | $3.12M | Buy |
10,978
+652
| +6% | +$185K | 0.02% | 621 |
|
|
2021
Q4 | $3.89M | Buy |
10,326
+220
| +2% | +$82.9K | 0.02% | 564 |
|
|
2021
Q3 | $4.17M | Buy |
10,106
+600
| +6% | +$248K | 0.02% | 517 |
|
|
2021
Q2 | $3.52M | Buy |
+9,506
| New | +$3.52M | 0.02% | 578 |
|